Xavier, F., Oliveira, F. D., Alves, A., Cunha, J. V. D., Monici, V., Costa, A., Misael, N. C. (2025). Venetoclax-based salvage therapy achieves high remission rates after 7+3 or low-dose cytarabine. Blood. https://doi.org/10.1182/blood-2025-8190